The strikes in Venezuela come at a time when drug-related deaths in the U.S. are falling sharply, down from a spike that occurred during the height of the Covid-19 pandemic. The decline began under ...

Teva delivers 3 consecutive years of growth - 2025 revenues of $17.3 billion, an increase of 4% year-over-year (YoY) in U.S. dollars, or 3% in ...

President Donald Trump’s deals with pharmaceutical companies are likely to have only a limited impact on Americans’ drug spending, experts say. Since Sept. 30, the Trump administration has struck ...

Teva delivers 3 consecutive years of growth - 2025 revenues of $17.3 billion, an increase of 4% year-over-year (YoY) in U.S. dollars, or 3% in local currency (LC) terms, compared to 2024. Excluding Ja ...